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Abstract
Patients with the very rare eye pathology Wagner disease (OMIM #143200) present with an abnormal 
(empty) vitreous, retinal detachment and altered electroretinogram (ERG). The disease is progressive 
and can eventually lead to blindness. No therapy can be offered to date. The genetic basis is the 
presence of mutations in the VCAN gene, encoding the large extracellular matrix molecule versican, 
which is a component of the vitreous. All identified mutations map to the canonical splice sites 
flanking exon 8, resulting in low number of aberrant splice products and a severe increase in two (V2, 
V3) of the four naturally occurring splice variants. The pathomechanism of Wagner's disease is poorly 
understood and a mouse model may afford further insight. The hdf -/- mice, named for their initial 
phenotype of heart defects, carry a null allele for Vcan that leads to embryonic lethality when 
homozygous, but heterozygote animals are viable. Here we investigated a possible eye phenotype in 
the heterozygous animals. While the overall morphology of retina and ciliary body appears to be 
normal, older (17 months) mutant animals show a decrease in ERG signaling profiles affecting the a-, 
b- and c-waves. This aspect of altered ERG profile demonstrates similarities to the human disease 
manifestation and underlines the suitability of heterozygous hdf+/- mice as a model for Wagner 
disease. 
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Figure
Retinal function and morphology of hdf+/- mice and their wild type siblings. 
Panel a: cross section of mouse retina to demonstrate morphological evaluations by measuring the 
thickness of the retina (left long red bar) and the outer nuclear layer (ONL) (right short red bar). 
Panel b: Quantitative evaluation of ERGs showing the average amplitude of the b-wave measured in 
six wild type (grey line) and six Vcan heterozygous mutant (hdf +/-) (green line) at the age of 17 
months. At a light intensity of 10 mcds/m2 a significant reduction in the mutant mice was observed, 
which remained significant with increasing light intensity. Error bars display confidence intervals at 
95%. 
Panel c: ERG evaluation of the c-wave amplitude obtained from the same mice as shown in panel b. 
Mutant mice show a statistically significant reduction of 27% in amplitude. 
Panel d: Haematoxilin staining of retina and ciliary body from four mutant (hdf+/- 1-4) and two wild 
type (WT1-2) animals at the age of 17 months. Representative images were chosen for each animal. 
The red boxes in the over view panel indicate the central and peripheral regions displayed in more 
detail (400x enlarged). Typical arrangement of retinal layers at central and peripheral positions show 
from left to right: RPE (redish-brownish color), followed by blue staining nuclei of the outer ONL and 
the inner nuclear layer (INL) and the ganglion cell layer (blue nuclei). The right column shows images 
of ciliary bodies. Scale for overview is 1mm, for enlarged areas 50µm. 
Panel e: Quantitative assessment of retinal thickness in same animals as panel e:.Top graphs show 
ratios measured at central retina (retina thickness (µm)/ONL thickness (µm)) and ONL thickness 
(µm)/number of nuclei in ONL. Bottom graphs show same measurements at the peripheral retinal 
position. For each animal 15 sections were measured. Displayed are the average values; error bars 
show confidence intervals.  Details for measurement are given in panel a. p=<0.05. 
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Introduction
Wagner disease (OMIM# 143200) is a rare autosomal dominant progressive disorder belonging to the 
group of hereditary vitreoretinal degenerations [1] http://www.ncbi.nlm.nih.gov/books/NBK3821/). 
Vision impairment causes a major handicap for the affected. Clinically, the disease presents typically 
with the hallmark features of an empty vitreous cavity with fibrillary condensations, avascular strands 
and veils. Additionally, chorio-retinal atrophy, which may be reflected in altered ERG, and peripheral 
tractional retinal detachment is frequently observed [2] [3]. The syndrome shows full penetrance with 
manifestation at early adolescence. The disease is furthermore characterized by more heterogeneous 
clinical aspects, i.e. cataracts and myopia [4]. As VCAN has been shown to be mutated in the 
majority of patients with Wagner syndrome, the potential pathomechanism likely involves the large 
core protein isoforms V0 and/or V1 of the extracellular matrix chondroitin sulfate proteoglycan 
versican with a length of 3396 and 2409 amino acids, respectively [5]. Furthermore, versican has 
been found as a component of the vitreous [6] [7]. To date all identified mutations in patients with 
Wagner disease map to the canonical splice sites bordering exon 8 [8] [9] [10] [11] [12] [13] [14]. 
Under normal conditions, four alternative splice isoforms are produced, which differ in the presence of 
exons 7 and 8 (variant V0 contains exon 7 and 8, V1 lacks exon 7, V2 lacks exon 8 and V3 lacks 
exon 7 and 8). It has been suggested that the splice site mutations lead to aberrant splice products 
and most strikingly to abnormal quantity of the normal transcript isoforms, in particular a dramatic 
increase in V2 [15] [5] [12]. The protein domains encoded by the large exons 7 and 8 carry 23 
potential glucosaminoglycan attachment sites [16], suggesting that the larger isoforms contribute to a 
gel-maintenance function within the vitreous. In order to shed more light on the disease mechanism, 
we explored the phenotype of the mouse mutant model hdf which carries a non-functional Vcan 
gene [17]. Mouse and human versican share a similar genomic organization of the gene with 77% 
identity at the DNA sequence level and 64% at the amino acid level, with variations spread 
throughout the protein rather than being clustered (http://www.ncbi.nlm.nih.gov/gene/, Jan 2016). 
Furthermore, alternative splicing of the two largest exons is conserved in both species yielding the 4 
isoforms [18]. These facts led us to investigate the suitability of Vcan knockout mice as a model for 
Wagner disease. Homozygous hdf mice (Vcan null) have previously been described; they are 
embryonic lethal due to severe heart and limb developmental defects [18] [17]. In contrast, 
heterozygous animals are viable and appear at first sight normal, but eye phenotypes have not been 
investigated. Since the Wagner disease phenotype is dominant and mutations are heterozygous, the 
occurrence of an eye phenotype in the heterozygous hdf+/- mouse mutant seemed plausible.    
Objective
In humans heterozygous mutations in the VCAN gene cause the dominantly inherited erosive 
vitreoretinopathy of Wagner disease. To understand the underlying pathophysiology we investigated 
the effects of the heterozygous vcan null mutation in hdf+/- mice on eyes. 




Electrophysiological response: At age 5.5 months and 12 months, the scotopic and photopic ERGs 
did not differ between mutant and wild type siblings (data not shown). Furthermore, ophthalmoscopic 
analysis of wild type and mutant mice at 5.5 months did not reveal a difference (data not shown). At 
age 17 months, in the mutant animal eyes, the b-wave amplitude of the scotopic ERG was 
significantly reduced by 22% on average (Figure 1b; 10 [mcds]: t(10)=3.9, P=0.00296; 100 [mcds]: t
(10)=3.97, P= 0.00264; 1000 [mcds]: t(10)=3.64, P= 0.00454; 3000 [mcds]: t(10)=4.06, P= 0.002287). 
The a-wave amplitude showed, for some light intensities, statistically significant differences (10 
[mcds]: t(10)=0.91, P=0.3824; 100 [mcds]: t(10)=2.99, P= 0.0136; 1000 [mcds]: t(10)=3.07, P= 
0.0118; 3000 [mcds]: t(10)=2.18, P= 0.0544; 30000 [mcds]: t(10)=2.69, P= 0.0228; 60000 [mcds]: t
(10)=2.02, P= 0.0710; 90000 [mcds]: t(10)=2.3, P= 0.0439; 300000 [mcds]: t(10)=1.95, P= 0.0797). 
The c-wave was also decreased (Figure 1c, t(10)=4.99, P=0.00054 ), indicating that in addition to 
photo-receptors and inner layer of retina, the retinal pigment epithelium (RPE) is also involved [19]. 
Histological analysis: Eyes from the individual mutants beforehand analyzed for ERG were subjected 
to histological analysis of the retina. All retinas displayed a proper morphological distribution of the 
various cell layers positioned at the central or peripheral retina or at the ciliary body when comparing 
heterozygous mutant and wild type siblings (Figure 1d). Furthermore, quantitative analysis of the 
thickness of the retina or the outer nuclear layer also did not reveal a difference between mutant and 
wild type siblings (Figure 1e, central and peripheral retina: ratio retina [µm] /ONL [µm] nuclei (t(4)
=0.03285, P=0.9754 and t(4)=0.3736, P=0.7277, respectively) and for ratio ONL[µm] /ONL nuclei (t(4)
=1.303, P=0.2624 and t(4)=2.724, P=0.0528, respectively). 
Taking the morphological and ERG studies together, a functional defect is likely due to reduced 
signaling from the retinal cells. Of note, a collagen (Col2a1) mouse model for Stickler Syndrome [20], 
a connective tissue disease with syndromic features affecting limbs and an eye phenotype very 
similar to that observed in Wagner disease [1] [21], was previously shown to display morphological 
alterations in the ciliary body only in older mice (18 months). Therefore, we also examined potential 
changes in the ciliary body in the hdf mouse strain. Based on image observation, no obvious 
difference between wild type and mutant animals could be detected (Figure 1d). 
Discussion
The dominantly inherited Wagner disease is associated with heterozygous mutations in the VCAN 
gene, leading to abnormal splicing. While the hallmark clinical phenotype is affecting the vitreous, 
retinal complications are common, also reflected by abnormal ERG [1] [3]. The hdf mouse model is 
characterized by a null mutation in the Vcan gene. We sought to explore an eye phenotype in 
heterozygous hdf+/- mice, possibly pheno-copying the human disease. In younger mice, no 
difference was seen between the wild type and mutant animals but the ERG showed abnormalities in 
older animals. A slight reduction of a-wave suggested that the photoreceptor cells are involved. A 
reduction of the b-wave implicated synaptic or post-synaptic effects on the bipolar cells. Generally, 
the b-wave may also be affected when the blood flow through the central retinal artery is blocked or 
the membrane potential of Müller cells is changed as result of an altered extracellular potassium 
concentration [22]. Which of these conditions apply here needs to be further investigated. In addition 
to the b-wave, the c-wave has also been reduced in the older hdf+/- mice, suggesting an involvement 
of the RPE or the RPE-photoreceptor complex. However, as the a-wave is normal a potential damage 
of the photoreceptors is at least not detectable. The c-wave is not a typical feature of the human 
ERG, but is found in several animals, including mice.  Interestingly, the age-related progressive 
nature of the phenotype in Wagner patients is mimicked in the hdf+/- mouse model, showing an 
altered retinal function at increased age. Whether also the patho-mechanism is comparable remains 
to be investigated because the mouse strain carries an expression null allele [17], while human 
patients still may express the two smallest splice variants V2 and V3 from the affected allele. It has 
been previously suggested that the splice defect might result in an imbalanced ratio of transcript 
isoforms that may lead to an imbalance of versican protein isoforms [10] [5] [12]. The observation 
that retinal morphology was not altered in hdf+/- mice suggests that the abnormal ERG response may 
be caused by cellular signaling defects rather than cell death. Furthermore, the intact ciliary body 
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suggests that the heterozygous null allele of Vcan does not exert a major structural function with 
respect to the ciliary body, unlike the Col2a1 null gene [20]. 
Conclusions
Taken together, a functional similarity of the hdf+/- mouse to the human Wagner disease has been 
demonstrated. However, further experiments are needed to establish the hdf-mouse strain as a valid 
animal model for this hereditary vitreoretinal degeneration.  
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The hdf+/- mouse strain was generated at the Department of Cell Biology and Anatomy, Medical 
University of South Carolina, Charleston, USA [14] . The animals were bred to yield a segregating, 
viable population of heterozygous and wild type siblings. Mice were kept at the Institute of Pathology, 
University of Zurich.  
ERG
At age 5.5 months, animals were transferred to the Department of Ophthalmology, Charité 
Universitätsmedizin, Berlin, Germany, where Ganzfeld ERG (scotopic and photopic 
electroretinogram)  measurements were performed as described [18] at age 5.5 months, 12 months 
and 17 months. After the last time point, twelve animals (six wild type and 6 hdf+/- mice) were 
sacrificed and eyes were removed for morphological analysis at the Institute of Medical and Molecular 
Genetics, University of Zurich. 
Histology
Eyes were fixed and embedded in paraffin and 2-3 µm sections were cut which were stained with 
haematoxylin-eosin as described [19]. Analysis was performed using Zeiss Axioplan2 imaging light 
microscopy. Sections were evaluated at the ciliary body and also at the central and peripheral retina. 
Thickness (µm) of entire retina and ONL (outer nuclear layer) as well as nuclei in the ONL were 
measured (Figure 1a). To correct for normal variation in eye sizes, statistical analysis was done after 
calculation of  the ratio of retinal thickness and OLN thickness and the ratio of ONL thickness and cell 
number in the ONL. For each of the 6 animals, (2 wild types and 4 hdf+/- mutants) three slides were 
evaluated to yield a total of 15 measurements per animal. For statistical evaluation GraphPad v5 was 
used, first to assess normal distribution of the data using D’Agostino & Pearson test and second to 
assess significance using 1-way ANOVA with Bartlett’s test. 
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